Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Beauloye

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|February 17, 2012
Myocardial metabolism in toxin-induced heart failure and therapeutic implicationsPhilippe Hantson, Christophe Beauloye
Cardiovascular Research|February 3, 2011
AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failureChristophe Beauloye, Luc Bertrand, Sandrine Horman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 8, 2013
Insulin resistance protects the heart from fuel overload in dysregulated metabolic statesHeinrich Taegtmeyer, Christophe Beauloye, Romain Harmancey, et al.
Essays in Biochemistry|September 25, 2024
AMPK and O-GlcNAcylation: interplay in cardiac pathologies and heart failureEttore Vanni, Christophe Beauloye, Sandrine Horman, et al.
Experientia Supplementum (2012)|November 5, 2016
Regulation of Carbohydrate Metabolism, Lipid Metabolism, and Protein Metabolism by AMPKYeliz Angin, Christophe Beauloye, Sandrine Horman, et al.
Cardiovascular Research|April 9, 2008
Insulin signalling in the heartLuc Bertrand, Sandrine Horman, Christophe Beauloye, et al.
Current Heart Failure Reports|July 7, 2012
AMP-activated protein kinase in the control of cardiac metabolism and remodelingSandrine Horman, Christophe Beauloye, Jean-Louis Vanoverschelde, et al.
Plos One|December 20, 2016
Impact of Hyperglycemia and Low Oxygen Tension on Adipose-Derived Stem Cells Compared with Dermal Fibroblasts and Keratinocytes: Importance for Wound Healing in Type 2 DiabetesAurore Lafosse, Cécile Dufeys, Christophe Beauloye, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 27, 2017
Real world insights on the initiation and treatment duration of oral antiplatelets in acute coronary syndromes: a retrospective cohort studyMarc J Claeys, Christophe Beauloye, Suzanne Pourbaix, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 19, 2024
Fibroblasts and platelets: a face-to-face dialogue at the heart of cardiac fibrosisCécile Dufeys, Julie Bodart, Luc Bertrand, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Clinical Toxicology (Philadelphia, Pa.)|February 17, 2012
Myocardial metabolism in toxin-induced heart failure and therapeutic implicationsPhilippe Hantson, Christophe Beauloye
Cardiovascular Research|February 3, 2011
AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failureChristophe Beauloye, Luc Bertrand, Sandrine Horman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 8, 2013
Insulin resistance protects the heart from fuel overload in dysregulated metabolic statesHeinrich Taegtmeyer, Christophe Beauloye, Romain Harmancey, et al.
Essays in Biochemistry|September 25, 2024
AMPK and O-GlcNAcylation: interplay in cardiac pathologies and heart failureEttore Vanni, Christophe Beauloye, Sandrine Horman, et al.
Experientia Supplementum (2012)|November 5, 2016
Regulation of Carbohydrate Metabolism, Lipid Metabolism, and Protein Metabolism by AMPKYeliz Angin, Christophe Beauloye, Sandrine Horman, et al.
Cardiovascular Research|April 9, 2008
Insulin signalling in the heartLuc Bertrand, Sandrine Horman, Christophe Beauloye, et al.
Current Heart Failure Reports|July 7, 2012
AMP-activated protein kinase in the control of cardiac metabolism and remodelingSandrine Horman, Christophe Beauloye, Jean-Louis Vanoverschelde, et al.
Plos One|December 20, 2016
Impact of Hyperglycemia and Low Oxygen Tension on Adipose-Derived Stem Cells Compared with Dermal Fibroblasts and Keratinocytes: Importance for Wound Healing in Type 2 DiabetesAurore Lafosse, Cécile Dufeys, Christophe Beauloye, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 27, 2017
Real world insights on the initiation and treatment duration of oral antiplatelets in acute coronary syndromes: a retrospective cohort studyMarc J Claeys, Christophe Beauloye, Suzanne Pourbaix, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 19, 2024
Fibroblasts and platelets: a face-to-face dialogue at the heart of cardiac fibrosisCécile Dufeys, Julie Bodart, Luc Bertrand, et al.
Pageof 15